Ventricular Arrhythmias and Implantable Cardioverter-Defibrillator Use in Patients with Left-Ventricular Assist Device: Validation of the VT-LVAD Prediction Score
Emmanuelle Massie(Université de Montréal), A. Ducharme(Montreal Heart Institute), Corrado De Marco(Université de Montréal), Blandine Mondésert(Montreal Heart Institute), Jacinthe Boulet(Montreal Heart Institute), P. Noly(Montreal Heart Institute)
Cited by 1
Related Papers
Inflammation in heart failure: pathophysiology and therapeutic strategies
|Inflammation Research|2024|129
Respiratory infections and the autumn increase in asthma morbidity
|European Respiratory Journal|1996|114
Statin Use and Risk of Vascular Events Among Cancer Patients After Radiotherapy to the Thorax, Head, and Neck
|Journal of the American Heart Association|2019|87
Clinical Experience With the Subcutaneous Implantable Cardioverter–Defibrillator in Adults With Congenital Heart Disease
|Circulation Arrhythmia and Electrophysiology|2016|80